PJ Online | PJ Letters: CPD (Continuing professional development)
The Pharmaceutical Journal
From Mr D. C. Shenton, MRPharmS
Dr Robin Harman has done the profession a considerable service with his article on the implications of mandatory continuing professional development for continued registration (PJ, 15 June, p844). He has set out for us with great clarity the extent of some real problems ? problems which, it appears, have just been shelved.
I intend Dr Harman no kind of criticism when I say that some of the questions he poses sit up and beg to be answered. Many of them were certainly asked by members in the original opinion-gathering exercise two or three years ago. How could they not have been? So far as I recall, there has been some indication of deliberations going on in the corridors of power, but answers are conspicuous by their absence. The mechanisms of CPD are now in parts being established; but the policies, beyond "we must have it" (with which I concur, in essence), are either being kept secret or have never been worked out.
Send your letter to The Editor
Citation: The Pharmaceutical Journal URI: 20007131
Recommended from Pharmaceutical Press
An innovative book which presents statistics in the context of clinical trials conducted during pharmaceutical drug development.£38.00Buy now